Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Heart Failure

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 211 articles:
HTML format



Single Articles


    January 2022
  1. XU Z, Neuber S, Nazari-Shafti T, Liu Z, et al
    Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure - a meta-analysis.
    PLoS One. 2022;17:e0261462.
    PubMed     Abstract available


  2. LI M, Li Y, Meng Q, Li Y, et al
    Correction: Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0262979.
    PubMed     Abstract available


  3. SHIBA M, Kato T, Morimoto T, Yaku H, et al
    Changes in BNP levels from discharge to 6-month visit predict subsequent outcomes in patients with acute heart failure.
    PLoS One. 2022;17:e0263165.
    PubMed     Abstract available


  4. LIU X, Liu H, Wang L, Zhang L, et al
    Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0263131.
    PubMed     Abstract available


  5. TONNESSEN TC, Melleby AO, Hauge-Iversen IM, Espe EKS, et al
    Impact of delayed type hypersensitivity arthritis on development of heart failure by aortic constriction in mice.
    PLoS One. 2022;17:e0262821.
    PubMed     Abstract available


  6. SAKUMA M, Toyoda S, Arikawa T, Koyabu Y, et al
    Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial.
    PLoS One. 2022;17:e0261445.
    PubMed     Abstract available


  7. ZHENG S, Yang J, Tan TC, Belani S, et al
    Dialysis therapy and mortality in older adults with heart failure and advanced chronic kidney disease: A high-dimensional propensity-matched cohort study.
    PLoS One. 2022;17:e0262706.
    PubMed     Abstract available


  8. SHIBATA T, Oishi S, Mizuno A, Ohmori T, et al
    Evaluation of the effectiveness of the physician education program on primary palliative care in heart failure.
    PLoS One. 2022;17:e0263523.
    PubMed     Abstract available


  9. CHAPMAN-GOETZ J, Packham N, Gabb G, Potts C, et al
    Acceptability and feasibility of the NPS MedicineWise mobile phone application in supporting medication adherence in patients with chronic heart failure: Protocol for a pilot study.
    PLoS One. 2022;17:e0263284.
    PubMed     Abstract available


  10. MARSHALL V, Jewett-Tennant J, Shell-Boyd J, Stevenson L, et al
    Healthcare providers experiences with shared medical appointments for heart failure.
    PLoS One. 2022;17:e0263498.
    PubMed     Abstract available


  11. LI N, Zhou G, Zheng Y, Lv D, et al
    Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis.
    PLoS One. 2022;17:e0261986.
    PubMed     Abstract available


  12. SONG J, Zhang Q, Ye L, Zheng Y, et al
    The comparison of catheter ablation on hard outcomes versus medical treatment for atrial fibrillation patients: A meta-analysis of randomized, controlled trials with trial sequential analysis.
    PLoS One. 2022;17:e0262702.
    PubMed     Abstract available


  13. ZHANG Y, Van Laer AO, Baicu CF, Neff LS, et al
    Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.
    PLoS One. 2022;17:e0262479.
    PubMed     Abstract available


  14. HODREA J, Saeed A, Molnar A, Fintha A, et al
    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
    PLoS One. 2022;17:e0263285.
    PubMed     Abstract available


  15. ALTAMURA M, D'Andrea G, Angelini E, Tortorelli FMP, et al
    Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients.
    PLoS One. 2022;17:e0265282.
    PubMed     Abstract available


  16. KUJAWSKI SA, Whitaker M, Ritchey MD, Reingold AL, et al
    Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017.
    PLoS One. 2022;17:e0264890.
    PubMed     Abstract available


  17. WAJANGA BMK, Kim CY, Peck RN, Bartlett J, et al
    Is lack of health insurance a predictor of worsening of heart failure among adult patients attending referral hospitals in Northwestern Tanzania?
    PLoS One. 2022;17:e0264352.
    PubMed     Abstract available


  18. DE JONG KA, Berisha F, Naderpoor N, Appelbe A, et al
    Polycystic ovarian syndrome increases prevalence of concentric hypertrophy in normotensive obese women.
    PLoS One. 2022;17:e0263312.
    PubMed     Abstract available


  19. LEE HJ, Kim HK, Lee SC, Ommen SR, et al
    Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
    PLoS One. 2022;17:e0264580.
    PubMed     Abstract available


  20. HARRISON NE, Meram S, Li X, White MB, et al
    Hemodynamic profiles by non-invasive monitoring of cardiac index and vascular tone in acute heart failure patients in the emergency department: External validation and clinical outcomes.
    PLoS One. 2022;17:e0265895.
    PubMed     Abstract available


  21. SAAD NS, Mashali MA, Elnakish MT, Hare A, et al
    Effect of hypothyroidism on contractile performance of isolated end-stage failing human myocardium.
    PLoS One. 2022;17:e0265731.
    PubMed     Abstract available


  22. SHROUT TA, Pan S, Mitchell GF, Vasan RS, et al
    Association of orthostatic blood pressure response with incident heart failure: The Framingham Heart Study.
    PLoS One. 2022;17:e0267057.
    PubMed     Abstract available


  23. BANERAS J, Pariggiano I, Rodenas-Alesina E, Oristrell G, et al
    Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how.
    PLoS One. 2022;17:e0266955.
    PubMed     Abstract available


  24. ANDERSON KM, Murphy D, Groninger H, Kolm P, et al
    Perceived symptoms as the primary indicators for 30-day heart failure readmission.
    PLoS One. 2022;17:e0267820.
    PubMed     Abstract available


  25. YAMAMOTO E, Kato T, Yaku H, Morimoto T, et al
    Appetite loss at discharge from acute decompensated heart failure: Observation from KCHF registry.
    PLoS One. 2022;17:e0267327.
    PubMed     Abstract available


  26. RIMBAS RC, Visoiu IS, Magda SL, Mihaila-Baldea S, et al
    New insights into the potential utility of the left atrial function analysis in heart failure with preserved ejection fraction diagnosis.
    PLoS One. 2022;17:e0267962.
    PubMed     Abstract available


  27. SHARA N, Bjarnadottir MV, Falah N, Chou J, et al
    Voice activated remote monitoring technology for heart failure patients: Study design, feasibility and observations from a pilot randomized control trial.
    PLoS One. 2022;17:e0267794.
    PubMed     Abstract available


    January 2021
  28. ISHAK WW, Korouri S, Darwish T, Vanle B, et al
    Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial.
    PLoS One. 2021;16:e0244453.
    PubMed     Abstract available


  29. LU XH, Liu A, Fuh SC, Lian Y, et al
    Recurrent disease progression networks for modelling risk trajectory of heart failure.
    PLoS One. 2021;16:e0245177.
    PubMed     Abstract available


  30. YAMAZAKI R, Nishiyama O, Yoshikawa K, Saeki S, et al
    HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure.
    PLoS One. 2021;16:e0245778.
    PubMed     Abstract available


  31. ALHABIB KF, Gamra H, Almahmeed W, Hammoudeh A, et al
    Correction: Acute Myocardial Infarction and Acute Heart Failure in the Middle East and North Africa: Study Design and Pilot Phase Study Results from the PEACE MENA Registry.
    PLoS One. 2021;16:e0246036.
    PubMed     Abstract available


  32. KAMATH DY, Bhuvana KB, Salazar LJ, Varghese K, et al
    A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failure.
    PLoS One. 2021;16:e0245659.
    PubMed     Abstract available


  33. OGUNTADE AS, Ajayi IO
    Risk factors of heart failure among patients with hypertension attending a tertiary hospital in Ibadan, Nigeria: The RISK-HHF case-control study.
    PLoS One. 2021;16:e0245734.
    PubMed     Abstract available


  34. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    PubMed     Abstract available


  35. FUNAMIZU T, Nagatomo Y, Saji M, Iguchi N, et al
    Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure.
    PLoS One. 2021;16:e0247140.
    PubMed     Abstract available


  36. YOLA IM, Oh A, Mitchell GF, O'Connor G, et al
    Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
    PLoS One. 2021;16:e0246355.
    PubMed     Abstract available


  37. PIERCE JB, Shah NS, Petito LC, Pool L, et al
    Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011-2018: A cross-sectional study.
    PLoS One. 2021;16:e0246813.
    PubMed     Abstract available


  38. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    PLoS One. 2021;16:e0247987.
    PubMed     Abstract available


  39. MCHORNEY CA, Mansukhani SG, Anatchkova M, Taylor N, et al
    The impact of heart failure on patients and caregivers: A qualitative study.
    PLoS One. 2021;16:e0248240.
    PubMed     Abstract available


  40. PUWANANT S, Sinphurmsukskul S, Krailak L, Nakaviroj P, et al
    The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure.
    PLoS One. 2021;16:e0249043.
    PubMed     Abstract available


  41. KAWADA K, Fukuda H, Kubo T, Ohta T, et al
    Added value of anxiolytic benzodiazepines in predictive models on severe delirium in patients with acute decompensated heart failure: A retrospective analysis.
    PLoS One. 2021;16:e0250372.
    PubMed     Abstract available


  42. BAMFORTH RJ, Chhibba R, Ferguson TW, Sabourin J, et al
    Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249542.
    PubMed     Abstract available


  43. ABE D, Inomata T
    Actual state of "triple therapy" for heart failure patients in eight regions of Japan: An analysis of a nationwide medical claims database.
    PLoS One. 2021;16:e0249711.
    PubMed     Abstract available


  44. MBOTWA JL, Kamps M, Baxter PD, Ellison GTH, et al
    Latent class regression improves the predictive acuity and clinical utility of survival prognostication amongst chronic heart failure patients.
    PLoS One. 2021;16:e0243674.
    PubMed     Abstract available


  45. LUPON J, Santiago-Vacas E, Cediel G, Codina P, et al
    Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
    PLoS One. 2021;16:e0249674.
    PubMed     Abstract available


  46. KANDA M, Tateishi K, Nakagomi A, Iwahana T, et al
    Association between early intensive care or coronary care unit admission and post-discharge performance of activities of daily living in patients with acute decompensated heart failure.
    PLoS One. 2021;16:e0251505.
    PubMed     Abstract available


  47. PONGIGLIONE B, Torbica A, Gale CP, Tavazzi L, et al
    Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: Prospective international cohort study.
    PLoS One. 2021;16:e0250931.
    PubMed     Abstract available


  48. ALGUREN B, Jernberg T, Vasko P, Selb M, et al
    Content comparison and person-centeredness of standards for quality improvement in cardiovascular health care.
    PLoS One. 2021;16:e0244874.
    PubMed     Abstract available


  49. ABID L, Charfeddine S, Kammoun I, Ben Halima M, et al
    Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF).
    PLoS One. 2021;16:e0251658.
    PubMed     Abstract available


  50. CHOU YY, Ward JL, Barron LZ, Murphy SD, et al
    Focused ultrasound of the caudal vena cava in dogs with cavitary effusions or congestive heart failure: A prospective, observational study.
    PLoS One. 2021;16:e0252544.
    PubMed     Abstract available


  51. TAKAHASHI S, Tanno K, Yonekura Y, Ohsawa M, et al
    Low educational level increases functional disability risk subsequent to heart failure in Japan: On behalf of the Iwate KENCO study group.
    PLoS One. 2021;16:e0253017.
    PubMed     Abstract available


  52. MAHESRI M, Chin K, Kumar A, Barve A, et al
    External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
    PLoS One. 2021;16:e0252903.
    PubMed     Abstract available


  53. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Cardiac index predicts long-term outcomes in patients with heart failure.
    PLoS One. 2021;16:e0252833.
    PubMed     Abstract available


  54. KATO M, Mori Y, Watanabe D, Onoda H, et al
    Relationship between average daily rehabilitation time and decline in instrumental activity of daily living among older patients with heart failure: A preliminary analysis of a multicenter cohort study, SURUGA-CARE.
    PLoS One. 2021;16:e0254128.
    PubMed     Abstract available


  55. KAWASE Y, Kato T, Morimoto T, Hata R, et al
    Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.
    PLoS One. 2021;16:e0253999.
    PubMed     Abstract available


  56. TANIGUCHI C, Seto N, Shimizu Y
    Outpatient nursing support for self-monitoring in patients with chronic heart failure.
    PLoS One. 2021;16:e0254019.
    PubMed     Abstract available


  57. HAMO CE, Abdelmoneim SS, Han SY, Chandy E, et al
    OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
    PLoS One. 2021;16:e0253014.
    PubMed     Abstract available


  58. GOLAND S, Volodarsky I, Fabricant Y, Livschitz S, et al
    Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
    PLoS One. 2021;16:e0254104.
    PubMed     Abstract available


  59. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    PubMed     Abstract available


  60. PRATTIPATI S, Sakita FM, Kweka GL, Tarimo TG, et al
    Heart failure care and outcomes in a Tanzanian emergency department: A prospective observational study.
    PLoS One. 2021;16:e0254609.
    PubMed     Abstract available


  61. LOKAJ P, Spinar J, Spinarova L, Malek F, et al
    Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
    PLoS One. 2021;16:e0255271.
    PubMed     Abstract available


  62. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Variable effects of underlying diseases on the prognosis of patients with COVID-19.
    PLoS One. 2021;16:e0254258.
    PubMed     Abstract available


  63. LI CX, Liang S, Gao L, Liu H, et al
    Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
    PLoS One. 2021;16:e0244689.
    PubMed     Abstract available


  64. RORTH R, Clausen MF, Fosbol EL, Mogensen UM, et al
    Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
    PLoS One. 2021;16:e0255364.
    PubMed     Abstract available


  65. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    PubMed     Abstract available


  66. ACHARYA R, Patel A, Schultz E, Bourgeois M, et al
    Fluid resuscitation and outcomes in heart failure patients with severe sepsis or septic shock: A retrospective case-control study.
    PLoS One. 2021;16:e0256368.
    PubMed     Abstract available


  67. BECK-FRIIS J, Leach S, Omerovic E, Zeijlon R, et al
    No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
    PLoS One. 2021;16:e0256035.
    PubMed     Abstract available


  68. TURRI-SILVA N, Vale-Lira A, Verboven K, Quaglioti Durigan JL, et al
    High-intensity interval training versus progressive high-intensity circuit resistance training on endothelial function and cardiorespiratory fitness in heart failure: A preliminary randomized controlled trial.
    PLoS One. 2021;16:e0257607.
    PubMed     Abstract available


  69. CHOUAIRI F, Mullan CW, Ravindra N, Clark KAA, et al
    Brief report: Cannabis and opioid use disorder among heart failure admissions, 2008-2018.
    PLoS One. 2021;16:e0255514.
    PubMed     Abstract available


  70. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    PubMed     Abstract available


  71. PERRY A, Loh F, Adamo L, Zhang KW, et al
    Unsupervised cluster analysis of patients with recovered left ventricular ejection fraction identifies unique clinical phenotypes.
    PLoS One. 2021;16:e0248317.
    PubMed     Abstract available


  72. CHUANG AM, Nguyen MT, Khan E, Jones D, et al
    Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    PLoS One. 2021;16:e0248289.
    PubMed     Abstract available


  73. LV S, Ru S
    The prevalence of malnutrition and its effects on the all-cause mortality among patients with heart failure: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259300.
    PubMed     Abstract available


  74. JONSSON HOLMDAHL A, Norberg H, Valham F, Bergdahl E, et al
    Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function.
    PLoS One. 2021;16:e0258949.
    PubMed     Abstract available


  75. IWAHANA T, Saito Y, Okada S, Kato H, et al
    Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study.
    PLoS One. 2021;16:e0259485.
    PubMed     Abstract available


  76. GALLARD A, Galli E, Hubert A, Bidaut A, et al
    Echocardiographic view and feature selection for the estimation of the response to CRT.
    PLoS One. 2021;16:e0252857.
    PubMed     Abstract available


  77. ITZHAKI BEN ZADOK O, Vaturi M, Vaxman I, Iakobishvili Z, et al
    Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
    PLoS One. 2021;16:e0255487.
    PubMed     Abstract available


  78. KITAGAWA Y, Kawamura I, Suzuki K, Okada H, et al
    Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival.
    PLoS One. 2021;16:e0260350.
    PubMed     Abstract available


  79. LI M, Li Y, Meng Q, Li Y, et al
    Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials.
    PLoS One. 2021;16:e0261300.
    PubMed     Abstract available


  80. DUONG SQ, Zheng L, Xia M, Jin B, et al
    Identification of patients at risk of new onset heart failure: Utilizing a large statewide health information exchange to train and validate a risk prediction model.
    PLoS One. 2021;16:e0260885.
    PubMed     Abstract available


  81. SUN Y, Pavey H, Wilkinson I, Fisk M, et al
    Role of the IL-33/ST2 axis in cardiovascular disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259026.
    PubMed     Abstract available


  82. KIM IS, Choi YJ, Choi EY, Min PK, et al
    Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
    PLoS One. 2021;16:e0258770.
    PubMed     Abstract available


  83. MONGILLO J, Vescovo G, Bramanti B
    Belly fat or bloating? New insights into the physical appearance of St Anthony of Padua.
    PLoS One. 2021;16:e0260505.
    PubMed     Abstract available


  84. SCAGLIONE A, Panzarino C, Modica M, Tavanelli M, et al
    Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device.
    PLoS One. 2021;16:e0259927.
    PubMed     Abstract available


  85. JOKI Y, Konishi H, Ebinuma H, Takasu K, et al
    Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.
    PLoS One. 2021;16:e0261753.
    PubMed     Abstract available


    January 2020
  86. LUND A, Nordrehaug JE, Slettom G, Hafstad Solvang SE, et al
    Plasma kynurenines and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0227365.
    PubMed     Abstract available


  87. THOMSON P, Howie K, Leslie SJ, Angus NJ, et al
    Evaluating emotional distress and health-related quality of life in patients with heart failure and their family caregivers: Testing dyadic dynamics using the Actor-Partner Interdependence Model.
    PLoS One. 2020;15:e0227129.
    PubMed     Abstract available


  88. MI-MI L, Farman GP, Mayfield RM, Strom J, et al
    In vivo elongation of thin filaments results in heart failure.
    PLoS One. 2020;15:e0226138.
    PubMed     Abstract available


  89. DI TANNA GL, Wirtz H, Burrows KL, Globe G, et al
    Evaluating risk prediction models for adults with heart failure: A systematic literature review.
    PLoS One. 2020;15:e0224135.
    PubMed     Abstract available


  90. MARTINS MATIAS A, Murucci Coelho P, Bermond Marques V, Dos Santos L, et al
    Hypercaloric diet models do not develop heart failure, but the excess sucrose promotes contractility dysfunction.
    PLoS One. 2020;15:e0228860.
    PubMed     Abstract available


  91. LUND A, Nordrehaug JE, Slettom G, Solvang SH, et al
    Correction: Plasma kynurenines and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0230056.
    PubMed     Abstract available


  92. STOCKIGT F, Eichhorn L, Beiert T, Knappe V, et al
    Heart failure after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous DES-p.R349P knock-in mice.
    PLoS One. 2020;15:e0228913.
    PubMed     Abstract available


  93. BRANDT EJ, Ross JS, Grady JN, Ahmad T, et al
    Impact of left ventricular assist devices and heart transplants on acute myocardial infarction and heart failure mortality and readmission measures.
    PLoS One. 2020;15:e0230734.
    PubMed     Abstract available


  94. FORRESTER SJ, Dolmatova EV, Griendling KK
    An acceleration in hypertension-related mortality for middle-aged and older Americans, 1999-2016: An observational study.
    PLoS One. 2020;15:e0225207.
    PubMed     Abstract available


  95. DI ACHILLE P, Parikh J, Khamzin S, Solovyova O, et al
    Model order reduction for left ventricular mechanics via congruency training.
    PLoS One. 2020;15:e0219876.
    PubMed     Abstract available


  96. VELAGALETI RS, Short MI, Larson MG, Vasan RS, et al
    Prognosis of "pre-heart failure" clinical phenotypes.
    PLoS One. 2020;15:e0231254.
    PubMed     Abstract available


  97. ROY B, Wolf JRLM, Carlson MD, Akkermans R, et al
    An international comparison of factors affecting quality of life among patients with congestive heart failure: A cross-sectional study.
    PLoS One. 2020;15:e0231346.
    PubMed     Abstract available


  98. JANKOWSKA-POLANSKA B, Swiatoniowska-Lonc N, Slawuta A, Krowczynska D, et al
    Patient-Reported Compliance in older age patients with chronic heart failure.
    PLoS One. 2020;15:e0231076.
    PubMed     Abstract available


  99. MOON I, Lee SY, Kim HK, Han KD, et al
    Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227012.
    PubMed     Abstract available


  100. KANAGALA P, Arnold JR, Singh A, Chan DCS, et al
    Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    PLoS One. 2020;15:e0232280.
    PubMed     Abstract available


  101. LUISO D, Villanueva JA, Belarte-Tornero LC, Fort A, et al
    Surface respiratory electromyography and dyspnea in acute heart failure patients.
    PLoS One. 2020;15:e0232225.
    PubMed     Abstract available


  102. NGUYEN ITN, Brandt MM, van de Wouw J, van Drie RWA, et al
    Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
    PLoS One. 2020;15:e0232399.
    PubMed     Abstract available


  103. CLAUSS S, Schuttler D, Bleyer C, Vlcek J, et al
    Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure.
    PLoS One. 2020;15:e0232374.
    PubMed     Abstract available


  104. GUYOT P, Djermoune EH, Chenuel B, Bastogne T, et al
    A signal demodulation-based method for the early detection of Cheyne-Stokes respiration.
    PLoS One. 2020;15:e0221191.
    PubMed     Abstract available


  105. JORBA G, Aguirre-Plans J, Junet V, Segu-Verges C, et al
    In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.
    PLoS One. 2020;15:e0228926.
    PubMed     Abstract available


  106. OTANI K, Higa Y, Kitano T, Nabeshima Y, et al
    Prediction of cardiac events using fully automated GLS and BNP titers in patients with known or suspected heart failure.
    PLoS One. 2020;15:e0234294.
    PubMed     Abstract available


  107. YOSHIOKA K, Matsue Y, Okumura T, Kida K, et al
    Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure.
    PLoS One. 2020;15:e0235493.
    PubMed     Abstract available


  108. ONUSKO E, McDermott MR, Robbins N, Liu G, et al
    Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy.
    PLoS One. 2020;15:e0230386.
    PubMed     Abstract available


  109. GROSS C, Fresiello L, Schloglhofer T, Dimitrov K, et al
    Hemodynamic exercise responses with a continuous-flow left ventricular assist device: Comparison of patients' response and cardiorespiratory simulations.
    PLoS One. 2020;15:e0229688.
    PubMed     Abstract available


  110. HARDT F, Becker M, Brandenburg V, Grebe J, et al
    Impact of epicardial adipose tissue volume upon left ventricular dysfunction in patients with mild-to-moderate aortic stenosis: A post-hoc analysis.
    PLoS One. 2020;15:e0229636.
    PubMed     Abstract available


  111. DI TANNA GL, Wirtz H, Burrows KL, Globe G, et al
    Correction: Evaluating risk prediction models for adults with heart failure: A systematic literature review.
    PLoS One. 2020;15:e0235970.
    PubMed     Abstract available


  112. PIEROBON A, Granata N, Torlaschi V, Vailati C, et al
    Psychomotor speed as a predictor of functional status in older chronic heart failure (CHF) patients attending cardiac rehabilitation.
    PLoS One. 2020;15:e0235570.
    PubMed     Abstract available


  113. LOOP MS, Van Dyke MK, Chen L, Brown TM, et al
    Evidence-based beta blocker use associated with lower heart failure readmission and mortality, but not all-cause readmission, among Medicare beneficiaries hospitalized for heart failure with reduced ejection fraction.
    PLoS One. 2020;15:e0233161.
    PubMed     Abstract available


  114. HUANG WM, Feng JY, Cheng HM, Chen SZ, et al
    The role of pulmonary function in patients with heart failure and preserved ejection fraction: Looking beyond chronic obstructive pulmonary disease.
    PLoS One. 2020;15:e0235152.
    PubMed     Abstract available


  115. GOTO T, Miyagawa S, Tamai K, Matsuura R, et al
    High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRalpha-positive bone marrow cells.
    PLoS One. 2020;15:e0230392.
    PubMed     Abstract available


  116. ALHABIB KF, Gamra H, Almahmeed W, Hammoudeh A, et al
    Acute myocardial infarction and acute heart failure in the Middle East and North Africa: Study design and pilot phase study results from the PEACE MENA registry.
    PLoS One. 2020;15:e0236292.
    PubMed     Abstract available


  117. CABRERA-AGUILERA I, Falcones B, Calvo-Fernandez A, Benito B, et al
    The conventional isoproterenol-induced heart failure model does not consistently mimic the diaphragmatic dysfunction observed in patients.
    PLoS One. 2020;15:e0236923.
    PubMed     Abstract available


  118. PAULUS MG, Meindl C, Bohm L, Holzapfel M, et al
    Predictors of functional improvement in the short term after MitraClip implantation in patients with secondary mitral regurgitation.
    PLoS One. 2020;15:e0232817.
    PubMed     Abstract available


  119. TAMAMURA Y, Matsuura M, Shiba S, Nishikimi T, et al
    Heart failure assessed based on plasma B-type natriuretic peptide (BNP) levels negatively impacts activity of daily living in patients with hip fracture.
    PLoS One. 2020;15:e0237387.
    PubMed     Abstract available


  120. SEID E, Engidawork E, Alebachew M, Mekonnen D, et al
    Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia.
    PLoS One. 2020;15:e0237781.
    PubMed     Abstract available


  121. GARCIMARTIN P, Comin-Colet J, Pardo-Cladellas Y, Badosa N, et al
    Validation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions.
    PLoS One. 2020;15:e0233338.
    PubMed     Abstract available


  122. MEINDL C, Hochadel M, Frankenstein L, Bruder O, et al
    The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registry.
    PLoS One. 2020;15:e0234260.
    PubMed     Abstract available


  123. SAILLARD C, Mallet D, Chow-Chine L, Bisbal M, et al
    Non-invasive ventilation indication for critically ill cancer patients admitted to the intensive care unit for acute respiratory failure (ARF) with associated cardiac dysfunction: Results from an observational study.
    PLoS One. 2020;15:e0234495.
    PubMed     Abstract available


  124. KIM J, Choi J, Shin MS, Kim M, et al
    Do advance directive attitudes and perceived susceptibility and end-of-life life-sustaining treatment preferences between patients with heart failure and cancer differ?
    PLoS One. 2020;15:e0238567.
    PubMed     Abstract available


  125. STROCCHI M, Augustin CM, Gsell MAF, Karabelas E, et al
    A publicly available virtual cohort of four-chamber heart meshes for cardiac electro-mechanics simulations.
    PLoS One. 2020;15:e0235145.
    PubMed     Abstract available


  126. IWAMIYA T, Segard BD, Matsuoka Y, Imamura T, et al
    Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis.
    PLoS One. 2020;15:e0237810.
    PubMed     Abstract available


  127. YOSHIKAWA Y, Tamaki Y, Morimoto T, Yaku H, et al
    Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
    PLoS One. 2020;15:e0239100.
    PubMed     Abstract available


  128. FRESIELLO L, Jacobs S, Timmermans P, Buys R, et al
    Limiting factors of peak and submaximal exercise capacity in LVAD patients.
    PLoS One. 2020;15:e0235684.
    PubMed     Abstract available


  129. OKA SI, Sabry AD, Horiuchi AK, Cawley KM, et al
    Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1.
    PLoS One. 2020;15:e0234913.
    PubMed     Abstract available


  130. MIN D, Park JS, Choi EY, Ahn JA, et al
    Comparison of learning needs priorities between healthcare providers and patients with heart failure.
    PLoS One. 2020;15:e0239656.
    PubMed     Abstract available


  131. HU Z, Du D
    A new analytical framework for missing data imputation and classification with uncertainty: Missing data imputation and heart failure readmission prediction.
    PLoS One. 2020;15:e0237724.
    PubMed     Abstract available


  132. PANDEY M, Xu Z, Sholle E, Maliakal G, et al
    Extraction of radiographic findings from unstructured thoracoabdominal computed tomography reports using convolutional neural network based natural language processing.
    PLoS One. 2020;15:e0236827.
    PubMed     Abstract available


  133. BOBILLO-PEREZ S, Girona-Alarcon M, Corniero P, Sole-Ribalta A, et al
    Pro-atrial natriuretic peptide and pro-adrenomedullin before cardiac surgery in children. Can we predict the future?
    PLoS One. 2020;15:e0236377.
    PubMed     Abstract available


  134. BLAZQUEZ-BERMEJO Z, Farre N, Llagostera M, Caravaca Perez P, et al
    The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry.
    PLoS One. 2020;15:e0240098.
    PubMed     Abstract available


  135. CARABALLO C, McCullough M, Fuery MA, Chouairi F, et al
    COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.
    PLoS One. 2020;15:e0238829.
    PubMed     Abstract available


  136. LI AH, Palmer KS, Taljaard M, Paterson JM, et al
    Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series study.
    PLoS One. 2020;15:e0236480.
    PubMed     Abstract available


  137. STOLINA M, Luo X, Dwyer D, Han CY, et al
    The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
    PLoS One. 2020;15:e0231234.
    PubMed     Abstract available


  138. OKANO T, Motoki H, Minamisawa M, Kimura K, et al
    Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure.
    PLoS One. 2020;15:e0241003.
    PubMed     Abstract available


  139. LANGSETH MS, Andersen GO, Husebye T, Arnesen H, et al
    Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure.
    PLoS One. 2020;15:e0241333.
    PubMed     Abstract available


  140. IACCARINO G, Grassi G, Borghi C, Carugo S, et al
    Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension.
    PLoS One. 2020;15:e0237297.
    PubMed     Abstract available


  141. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
    Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    PLoS One. 2020;15:e0238440.
    PubMed     Abstract available


  142. BAVISHI A, Lloyd-Jones DM, Ning H, Vu THT, et al
    Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure.
    PLoS One. 2020;15:e0240567.
    PubMed     Abstract available


  143. LIU N, Hang T, Gao X, Yang W, et al
    The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
    PLoS One. 2020;15:e0238775.
    PubMed     Abstract available


  144. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
    Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
    PLoS One. 2020;15:e0241361.
    PubMed     Abstract available


  145. SOHN A, Speier W, Lan E, Aoki K, et al
    Integrating remote monitoring into heart failure patients' care regimen: A pilot study.
    PLoS One. 2020;15:e0242210.
    PubMed     Abstract available


  146. MORBACH C, Sahiti F, Tiffe T, Cejka V, et al
    Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study.
    PLoS One. 2020;15:e0239684.
    PubMed     Abstract available


  147. MEZZACAPPA C, Ravindra NG, Caraballo C, Chouairi F, et al
    Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure.
    PLoS One. 2020;15:e0242928.
    PubMed     Abstract available


  148. CHECA C, Medina-Perucha L, Munoz MA, Verdu-Rotellar JM, et al
    Living with advanced heart failure: A qualitative study.
    PLoS One. 2020;15:e0243974.
    PubMed     Abstract available


  149. TING SW, Fan PC, Lin YS, Lin MS, et al
    Uremic pruritus and long-term morbidities in the dialysis population.
    PLoS One. 2020;15:e0241088.
    PubMed     Abstract available


  150. HAMMOND MM, Shen C, Li S, Kazi DS, et al
    Retrospective evaluation of echocardiographic variables for prediction of heart failure hospitalization in heart failure with preserved versus reduced ejection fraction: A single center experience.
    PLoS One. 2020;15:e0244379.
    PubMed     Abstract available


  151. KRUIK-KOLLOFFEL WJ, van der Palen J, Doggen CJM, van Maaren MC, et al
    Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.
    PLoS One. 2020;15:e0244231.
    PubMed     Abstract available


  152. VERHESTRAETEN C, Weijers G, Debleu D, Ciarka A, et al
    Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement.
    PLoS One. 2020;15:e0244485.
    PubMed     Abstract available


  153. SATO Y, Yoshihisa A, Watanabe K, Hotsuki Y, et al
    Association between platelet distribution width and prognosis in patients with heart failure.
    PLoS One. 2020;15:e0244608.
    PubMed     Abstract available


  154. KATO T, Yaku H, Morimoto T, Inuzuka Y, et al
    Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study.
    PLoS One. 2020;15:e0243818.
    PubMed     Abstract available


  155. DASSANAYAKA S, Brittian KR, Long BW, Higgins LA, et al
    Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    PLoS One. 2020;15:e0242250.
    PubMed     Abstract available


  156. HER AY, Choi BG, Rha SW, Kim YH, et al
    The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
    PLoS One. 2020;15:e0242314.
    PubMed     Abstract available


  157. DE NATTES T, Litzler PY, Gay A, Nafeh-Bizet C, et al
    Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy.
    PLoS One. 2020;15:e0242931.
    PubMed     Abstract available


  158. SALONEN J, Vahanikkila H, Purokivi M, Kaarteenaho R, et al
    Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
    PLoS One. 2020;15:e0242860.
    PubMed     Abstract available


  159. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available


  160. JONES E, Wei J, Nelson MD, Bakir M, et al
    N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    PLoS One. 2020;15:e0243213.
    PubMed     Abstract available


  161. BARENFELD E, Ali L, Wallstrom S, Fors A, et al
    Becoming more of an insider: A grounded theory study on patients' experience of a person-centred e-health intervention.
    PLoS One. 2020;15:e0241801.
    PubMed     Abstract available


  162. KAZMI SZH, Habib N, Riaz R, Rizvi SS, et al
    Multiscale based nonlinear dynamics analysis of heart rate variability signals.
    PLoS One. 2020;15:e0243441.
    PubMed     Abstract available


    January 2019
  163. CHANG TE, Park S, Yang Q, Loustalot F, et al
    Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults.
    PLoS One. 2019;14:e0222868.
    PubMed     Abstract available


  164. MOON YJ, Kim JW, Bang YS, Lim YS, et al
    Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment.
    PLoS One. 2019;14:e0209100.
    PubMed     Abstract available


  165. SUN CY, Sung JM, Wang JD, Li CY, et al
    A comparison of the risk of congestive heart failure-related hospitalizations in patients receiving hemodialysis and peritoneal dialysis - A retrospective propensity score-matched study.
    PLoS One. 2019;14:e0223336.
    PubMed     Abstract available


  166. BACKHAUS SJ, Metschies G, Billing M, Kowallick JT, et al
    Cardiovascular magnetic resonance imaging feature tracking: Impact of training on observer performance and reproducibility.
    PLoS One. 2019;14:e0210127.
    PubMed     Abstract available


  167. ABU-HALIMA M, Meese E, Saleh MA, Keller A, et al
    Micro-RNA 150-5p predicts overt heart failure in patients with univentricular hearts.
    PLoS One. 2019;14:e0223606.
    PubMed     Abstract available


  168. ANDERSSON C, Lyass A, Xanthakis V, Larson MG, et al
    Risk factor-based subphenotyping of heart failure in the community.
    PLoS One. 2019;14:e0222886.
    PubMed     Abstract available


  169. LENZI J, Avaldi VM, Molinazzi D, Descovich C, et al
    Are degree of urbanisation and travel times to healthcare services associated with the processes of care and outcomes of heart failure? A retrospective cohort study based on administrative data.
    PLoS One. 2019;14:e0223845.
    PubMed     Abstract available


  170. AXELSEN JB, Andersen S, Sun XQ, Ringgaard S, et al
    Effects of 6-mercaptopurine in pressure overload induced right heart failure.
    PLoS One. 2019;14:e0225122.
    PubMed     Abstract available


  171. HWANG JK, Gwag HB, Park KM, On YK, et al
    Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
    PLoS One. 2019;14:e0210603.
    PubMed     Abstract available


  172. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Outcome of patients with heart failure after transcatheter aortic valve implantation.
    PLoS One. 2019;14:e0225473.
    PubMed     Abstract available


  173. GHAZAL F, Theobald H, Rosenqvist M, Al-Khalili F, et al
    Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care.
    PLoS One. 2019;14:e0212974.
    PubMed     Abstract available


  174. DIETL A, Winkel I, Pietrzyk G, Paulus M, et al
    Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition.
    PLoS One. 2019;14:e0225937.
    PubMed     Abstract available


  175. KAUFMANN D, Szwoch M, Kwiatkowska J, Raczak G, et al
    Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction.
    PLoS One. 2019;14:e0225829.
    PubMed     Abstract available


  176. WESTHOFEN S, Jelinek M, Dreher L, Biermann D, et al
    The heterotopic heart transplantation in mice as a small animal model to study mechanical unloading - Establishment of the procedure, perioperative management and postoperative scoring.
    PLoS One. 2019;14:e0214513.
    PubMed     Abstract available


  177. POWER AS, Norman R, Jones TLM, Hickey AJ, et al
    Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment.
    PLoS One. 2019;14:e0214740.
    PubMed     Abstract available


  178. MAO CT, Chen TH, Tseng CN, Chen SW, et al
    Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.
    PLoS One. 2019;14:e0214417.
    PubMed     Abstract available


  179. VAN DEN HOOGEN P, de Jager SCA, Mol EA, Schoneveld AS, et al
    Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure.
    PLoS One. 2019;14:e0227283.
    PubMed     Abstract available


  180. SORIMACHI H, Kurosawa K, Yoshida K, Obokata M, et al
    Sex differences in left ventricular afterload and diastolic function are independent from the aortic size.
    PLoS One. 2019;14:e0214907.
    PubMed     Abstract available


  181. DECKX S, Johnson DM, Rienks M, Carai P, et al
    Extracellular SPARC increases cardiomyocyte contraction during health and disease.
    PLoS One. 2019;14:e0209534.
    PubMed     Abstract available


  182. HUANG TL, Hsiao FY, Chiang CK, Shen LJ, et al
    Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study.
    PLoS One. 2019;14:e0215248.
    PubMed     Abstract available


  183. BRAT K, Stastna N, Merta Z, Olson LJ, et al
    Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome.
    PLoS One. 2019;14:e0215997.
    PubMed     Abstract available


  184. MCCOY IE, Chertow GM, Chang TI
    Patterns of diuretic use in the intensive care unit.
    PLoS One. 2019;14:e0217911.
    PubMed     Abstract available


  185. EGAN BM, Sutherland SE, Tilkemeier PL, Davis RA, et al
    A cluster-based approach for integrating clinical management of Medicare beneficiaries with multiple chronic conditions.
    PLoS One. 2019;14:e0217696.
    PubMed     Abstract available


  186. REED ME, Huang J, Brand RJ, Neugebauer R, et al
    Patients with complex chronic conditions: Health care use and clinical events associated with access to a patient portal.
    PLoS One. 2019;14:e0217636.
    PubMed     Abstract available


  187. XUE Y, Xu B, Su C, Han Q, et al
    Cardiorenal syndrome in incident peritoneal dialysis patients: What is its effect on patients' outcomes?
    PLoS One. 2019;14:e0218082.
    PubMed     Abstract available


  188. PARK J, Lee J, Kwon A, Choi HJ, et al
    The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation.
    PLoS One. 2019;14:e0215603.
    PubMed     Abstract available


  189. COZZOLINO F, Montedori A, Abraha I, Eusebi P, et al
    A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project.
    PLoS One. 2019;14:e0218919.
    PubMed     Abstract available


  190. HAN J, Kubala M, Aranda-Michel E, Trumble DR, et al
    Ventricle-specific epicardial pressures as a means to optimize direct cardiac compression for circulatory support: A pilot study.
    PLoS One. 2019;14:e0219162.
    PubMed     Abstract available


  191. BATLLE M, Castillo N, Alcarraz A, Sarvari S, et al
    Axl expression is increased in early stages of left ventricular remodeling in an animal model with pressure-overload.
    PLoS One. 2019;14:e0217926.
    PubMed     Abstract available


  192. SANTOS JUNIOR OR, da Costa Rocha MO, Rodrigues de Almeida F, Sales da Cunha PF, et al
    Speckle tracking echocardiographic deformation indices in Chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain.
    PLoS One. 2019;14:e0221028.
    PubMed     Abstract available


  193. DELGADO GE, Zirlik A, Gruber R, Scheffold T, et al
    The association of high-normal international-normalized-ratio (INR) with mortality in patients referred for coronary angiography.
    PLoS One. 2019;14:e0221112.
    PubMed     Abstract available


  194. NGUYEN QL, Wang Y, Helbling N, Simon MA, et al
    Alterations in platelet bioenergetics in Group 2 PH-HFpEF patients.
    PLoS One. 2019;14:e0220490.
    PubMed     Abstract available


  195. ROUBICEK T, Stros J, Kucera P, Nedbal P, et al
    Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
    PLoS One. 2019;14:e0219966.
    PubMed     Abstract available


  196. HEARN J, Ssinabulya I, Schwartz JI, Akiteng AR, et al
    Self-management of non-communicable diseases in low- and middle-income countries: A scoping review.
    PLoS One. 2019;14:e0219141.
    PubMed     Abstract available


  197. PHILIP JL, Xu X, Han M, Akhter SA, et al
    Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by beta-arrestins.
    PLoS One. 2019;14:e0219011.
    PubMed     Abstract available


  198. ADELBORG K, Nicolaisen SK, Hasvold P, Palaka E, et al
    Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.
    PLoS One. 2019;14:e0218739.
    PubMed     Abstract available


  199. ARANDA-MICHEL E, Waldman LK, Trumble DR
    Left ventricular simulation of cardiac compression: Hemodynamics and regional mechanics.
    PLoS One. 2019;14:e0224475.
    PubMed     Abstract available


  200. BOZKURT S
    Mathematical modeling of cardiac function to evaluate clinical cases in adults and children.
    PLoS One. 2019;14:e0224663.
    PubMed     Abstract available


  201. OUD L
    In-hospital cardiopulmonary resuscitation of patients with cirrhosis: A population-based analysis.
    PLoS One. 2019;14:e0222873.
    PubMed     Abstract available


  202. TAKEJI Y, Taniguchi T, Morimoto T, Saito N, et al
    Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice.
    PLoS One. 2019;14:e0222979.
    PubMed     Abstract available


  203. BLANC AL, Fumeaux T, Stirnemann J, Dupuis Lozeron E, et al
    Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patients.
    PLoS One. 2019;14:e0219348.
    PubMed     Abstract available


  204. NACHAR W, Merlet N, Maafi F, Shi Y, et al
    Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits.
    PLoS One. 2019;14:e0220707.
    PubMed     Abstract available


  205. MONTENEGRO CAMANHO LE, Benchimol Saad E, Slater C, Oliveira Inacio Junior LA, et al
    Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy.
    PLoS One. 2019;14:e0225612.
    PubMed     Abstract available


  206. AHMED MM, Roukoz H, Trivedi JR, Bhan A, et al
    Questionable utility of digoxin in left-ventricular assist device recipients: A multicenter, retrospective analysis.
    PLoS One. 2019;14:e0225628.
    PubMed     Abstract available


  207. INGRASCIOTTA Y, Sultana J, Giorgianni F, Menditto E, et al
    Analgesic drug use in elderly persons: A population-based study in Southern Italy.
    PLoS One. 2019;14:e0222836.
    PubMed     Abstract available


  208. STEVENS M, Shenoy AV, Munson SH, Yapici HO, et al
    Healthcare utilization and costs of cardiopulmonary complications following cardiac surgery in the United States.
    PLoS One. 2019;14:e0226750.
    PubMed     Abstract available


  209. BERENT TE, Dorschner JM, Meyer T, Craig TA, et al
    Impaired cardiac performance, protein synthesis, and mitochondrial function in tumor-bearing mice.
    PLoS One. 2019;14:e0226440.
    PubMed     Abstract available


  210. OTA Y, Kitamura M, Muta K, Yamashita H, et al
    Effect of statin on life prognosis in Japanese patients undergoing hemodialysis.
    PLoS One. 2019;14:e0224111.
    PubMed     Abstract available


  211. GERGS U, Jahn T, Werner F, Kohler C, et al
    Overexpression of protein phosphatase 5 in the mouse heart: Reduced contractility but increased stress tolerance - Two sides of the same coin?
    PLoS One. 2019;14:e0221289.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: